Historical record - last NADAC effective date: 8/18/2021
Product Information
OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $4.2477 per ML under NDC 62332050203. Its NADAC has been published 71 times since Apr 29, 2020.
FDA first approved this application on Apr 29, 2019.
Strength
2 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332050203
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/18/2021
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209420FDA Approved
4/29/2019
On Market Since
4/29/2019
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 71 times since Apr 29, 2020, and over the history we have for it it has declined 26.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2477 per ML |
|---|---|
| All-time high | $5.8621 (Jul 14, 2021) |
| All-time low | $4.2477 (Aug 18, 2021) |
| Median price | $5.0379 |
| Average price | $5.0475 |
| Largest weekly change | -26.6% (Jul 21, 2021) |
| Weeks tracked | 71 |
| Tracking since | Apr 29, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-26.8%
Last surveyed Sep 1, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olopatadine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
olopatadine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Alembic Pharmaceuticals Inc., is $4.2477 per ML (NDC 62332050203), effective Sep 1, 2021.
How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 26.8%. It has been tracked across 71 weekly CMS publications since Apr 29, 2020.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?
Since Apr 29, 2020, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $4.2477 (Aug 18, 2021) to a high of $5.8621 (Jul 14, 2021), with a median of $5.0379 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of OLOPATADINE HCL 0.2% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OLOPATADINE HCL 0.2% EYE DROP?
OLOPATADINE HCL 0.2% EYE DROP (NDC 62332050203) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.